ConcertAI
Founded Year
2017Stage
Series C | AliveTotal Raised
$320MValuation
$0000Last Raised
$150M | 3 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-51 points in the past 30 days
About ConcertAI
ConcertAI is a leader in clinical artificial intelligence and real-world data products within the healthcare sector. The company offers a suite of AI-driven solutions and services designed to optimize clinical trials, provide predictive patient insights, and support commercial healthcare solutions. ConcertAI primarily serves the oncology research and clinical development sectors. It was founded in 2017 and is based in Cambridge, Massachusetts.
Loading...
ESPs containing ConcertAI
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The real-world data providers market offers a variety of value propositions to the pharmaceutical industry, drug labs, and healthcare organizations. It provides access to diverse patient populations, longitudinal real-world data, and patient-powered or EHR-powered controls that can replicate real-world scenarios. This can help shorten drug development timelines, reduce patient recruitment burdens …
ConcertAI named as Leader among 15 other companies, including Tempus, Syapse, and TriNetX.
Loading...
Research containing ConcertAI
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned ConcertAI in 6 CB Insights research briefs, most recently on Aug 21, 2024.
Aug 21, 2024
The clinical trials tech market map
Feb 16, 2022
The 130+ AI startups reinventing healthcareExpert Collections containing ConcertAI
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ConcertAI is included in 8 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,249 items
AI 100
100 items
The winners of the 4th annual CB Insights AI 100.
Conference Exhibitors
5,302 items
Digital Health 50
150 items
The winners of the second annual CB Insights Digital Health 150.
Digital Health
11,109 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
ConcertAI Patents
ConcertAI has filed 1 patent.
The 3 most popular patent topics include:
- artificial neural networks
- classification algorithms
- machine learning
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/29/2021 | Machine learning, Artificial neural networks, Classification algorithms, Machine learning algorithms, Statistical classification | Application |
Application Date | 10/29/2021 |
|---|---|
Grant Date | |
Title | |
Related Topics | Machine learning, Artificial neural networks, Classification algorithms, Machine learning algorithms, Statistical classification |
Status | Application |
Latest ConcertAI News
Oct 23, 2024
What You Should Know: – TeraRecon , the leader in medical imaging advanced visualization, clinical AI, and workflow automation, today announced updates to its Intuition platform with new best-in-class cardiac magnetic resonance (MR) medical imaging capabilities. – These clinical innovations are now available across all deployment models and on the latest cloud infrastructure. ConcertAI and Intuition: Advancing Healthcare with AI-Driven Research and Diagnostic Solutions ConcertAI stands as a leader in predictive and generative AI SaaS solutions, specializing in Real-World Data (RWD) research for healthcare and life sciences. Its mission is to drive faster insights and improved outcomes for patients by leveraging research-ready data, cutting-edge AI technologies, and deep scientific expertise. By partnering with top biomedical innovators, healthcare providers, and medical societies, ConcertAI enhances patient care through its robust AI-driven platforms. Intuition, a core product, focuses on enhancing cardiac diagnostics and clinical workflows through its comprehensive cardiac modules. The latest release, Intuition 4.10, features over 200 enhancements based on user feedback, particularly from cardiac imaging experts. Key improvements include: – A specialized cardiac MR viewer with optimized hanging protocols – Seamless measurement and reporting capabilities for cardiac MR cases – Advanced tools such as contouring, T1/T2/T2* mapping, 2D flow analysis, strain analysis, and perfusion quantification, all designed to offer deeper insights into cardiac function, enabling confident diagnoses and informed treatment plans. Intuition’s AI-powered workflows significantly boost clinical decision-making across various specialties. Through strategic partnerships with leading third-party AI vendors, the platform augments diagnostic precision and planning. Notable applications include: – Oncology: AI-driven lung nodule screening and detection for improved early diagnosis. – Cardiology: Accelerated coronary disease assessment through precise Ca scoring computations. – Radiology: Automated detection of bone fractures, breast density measurement, MR brain perfusion, and more. This integration of AI across multiple medical disciplines makes Intuition an essential tool for clinicians seeking to improve diagnostic accuracy and treatment outcomes. “TeraRecon’s Intuition 4.10 release includes significant new enhancements to cardiac MR workflows,” said Dr. Christopher Maroules MD, COO of Innovation Health Services. “I have been using TeraRecon’s Cardiac CT capabilities for decades. This release allows me to start standardizing my post-processing cardiac workflows onto a single, broad tool for imaging workflows. The versatility of the dedicated cardiac MR viewer and various cardiac MR workflows enable me to conduct my day-to-day cardiac MR analysis in a streamlined and consistent manner.”
ConcertAI Frequently Asked Questions (FAQ)
When was ConcertAI founded?
ConcertAI was founded in 2017.
Where is ConcertAI's headquarters?
ConcertAI's headquarters is located at 1120 Massachusetts Avenue, Cambridge.
What is ConcertAI's latest funding round?
ConcertAI's latest funding round is Series C.
How much did ConcertAI raise?
ConcertAI raised a total of $320M.
Who are the investors of ConcertAI?
Investors of ConcertAI include Sixth Street Partners, Maverick Ventures Israel, Declaration Partners, SymphonyAI, AllianceBernstein and 3 more.
Who are ConcertAI's competitors?
Competitors of ConcertAI include Mendel AI, Zephyr AI, Holmusk, nference, COTA and 7 more.
Loading...
Compare ConcertAI to Competitors
Owkin operates as an artificial intelligence (AI)-based biotechnology company. It utilizes AI to enhance the process of finding suitable treatments for patients. The company's main services include the use of AI to identify new treatments, accelerate clinical trials, and build diagnostic tools. It enables researchers in hospitals, universities, and the biopharmaceutical industry to understand how drug efficacy varies for the improvement of drug development. Its services primarily cater to the biopharmaceutical and academic research sectors. It was founded in 2016 and is based in New York, New York.
Aetion operates as a healthcare analytics company. It provides decision-grade real-world evidence solutions to biopharma companies, payers, and regulatory agencies. It offers a platform that analyzes data from the real world to produce scientifically validated answers on treatments, effectiveness, and value. The company was founded in 2012 and is based in New York, New York.
Promptly Health is a global provider of end-to-end Real World Evidence solutions in the healthcare sector. The company's main services include the generation of new knowledge from harmonized clinical, socio-economic, and claims data, augmented with the collection of longitudinal patient-reported data and patient-generated digital biomarkers. Promptly Health primarily sells to the life sciences sector, healthcare providers, and healthcare payers. It was founded in 2017 and is based in Porto, Portugal.
Verantos is a company that focuses on generating high-validity real-world evidence in the life sciences sector. The company offers a platform that integrates various real-world data sources and uses artificial intelligence to generate evidence with high accuracy, completeness, and traceability. This evidence is used to accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives across all therapeutic areas. It was founded in 2015 and is based in Menlo Park, California.
nference is a science-first software company that focuses on transforming unstructured data from electronic medical records (EMR) into powerful software solutions in the healthcare and life sciences industry. The company's main services include the development of software products that enable the synthesis of biomedical information, the creation of AI-enabled solutions for healthcare, and the provision of tools that unlock insights from structured and unstructured patient records. nference primarily sells to the healthcare ecosystem, with a focus on medical centers and biopharmaceutical companies. It was founded in 2013 and is based in Cambridge, Massachusetts.
Holmusk is a data analytics and health technology company focused on behavioral health. The company offers a real-world evidence platform that leverages AI-powered analytics and digital solutions to improve research and care in behavioral health. Holmusk's main services include providing access to a comprehensive behavioral health database, advanced data analytics software, and an electronic health records platform designed for psychiatry practices. It was founded in 2015 and is based in New York, New York.
Loading...